Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. j. med. biol. res ; 40(10): 1287-1304, Oct. 2007. ilus, tab
Article in English | LILACS | ID: lil-461366

ABSTRACT

The pharmacology of synthetic organoselenium compounds indicates that they can be used as antioxidants, enzyme inhibitors, neuroprotectors, anti-tumor and anti-infectious agents, and immunomodulators. In this review, we focus on the effects of diphenyl diselenide (DPDS) in various biological model organisms. DPDS possesses antioxidant activity, confirmed in several in vitro and in vivo systems, and thus has a protective effect against hepatic, renal and gastric injuries, in addition to its neuroprotective activity. The activity of the compound on the central nervous system has been studied since DPDS has lipophilic characteristics, increasing adenylyl cyclase activity and inhibiting glutamate and MK-801 binding to rat synaptic membranes. Systemic administration facilitates the formation of long-term object recognition memory in mice and has a protective effect against brain ischemia and on reserpine-induced orofacial dyskinesia in rats. On the other hand, DPDS may be toxic, mainly because of its interaction with thiol groups. In the yeast Saccharomyces cerevisiae, the molecule acts as a pro-oxidant by depleting free glutathione. Administration to mice during cadmium intoxication has the opposite effect, reducing oxidative stress in various tissues. DPDS is a potent inhibitor of d-aminolevulinate dehydratase and chronic exposure to high doses of this compound has central effects on mouse brain, as well as liver and renal toxicity. Genotoxicity of this compound has been assessed in bacteria, haploid and diploid yeast and in a tumor cell line.


Subject(s)
Animals , Mice , Rats , Antioxidants/pharmacology , Benzene Derivatives/pharmacology , Organoselenium Compounds/pharmacology , Porphobilinogen Synthase/antagonists & inhibitors , Saccharomyces cerevisiae/drug effects , Benzene Derivatives/toxicity , Models, Biological , Mutagenicity Tests , Organoselenium Compounds/toxicity
2.
Indian J Exp Biol ; 2007 Apr; 45(4): 385-9
Article in English | IMSEAR | ID: sea-57534

ABSTRACT

Supply of cadmium chloride (0.5 mM) inhibited chlorophyll formation in greening maize leaf segments, while lower concentration of Cd (0.01 mM) slightly enhanced it. Inclusion of 2-oxoglutarate (2-OG, 0.1-10 mM) in the incubation mixture increased chlorophyll content in the absence as well as presence of Cd. Substantial inhibition of chlorophyll formation by Cd was observed at longer treatment both in the absence and presence of 2-OG. When the tissue was pre-incubated with 2-OG or Cd, the inhibition (%) of chlorophyll formation by Cd was lowered in the presence of 2-OG. Treatment with Cd inhibited ALAD activity and ALA formation and the inhibition (%) of ALA formation by Cd was strongly reduced in the presence of 2-OG. Glutamate dehydrogenase (GDH) activity was increased by the supply of Cd both in the absence as well as presence of 2-OG. In the presence of 2-OG, Cd supply significantly increased glutamate synthase (GOGAT) activity and reduced inhibition (%) of glutamine synthetase (GS) activity. The results suggested the involvement of the glutamine synthetase/glutamate synthase (GS/GOGAT) pathway of ammonia assimilation to provide the precursor, glutamate, for ALA synthesis under Cd toxicity and 2-OG supplementation.


Subject(s)
Aminolevulinic Acid/antagonists & inhibitors , Cadmium Chloride/pharmacology , Chlorophyll/antagonists & inhibitors , Ketoglutaric Acids/pharmacology , Plant Leaves/drug effects , Porphobilinogen Synthase/antagonists & inhibitors , Quaternary Ammonium Compounds/metabolism , Zea mays/drug effects
3.
Braz. j. med. biol. res ; 32(6): 761-6, Jun. 1999. tab
Article in English | LILACS | ID: lil-233709

ABSTRACT

The purpose of the present study was to investigate the in vitro and in vivo effects of aluminum sulfate on delta-aminolevulinic acid dehydratase (ALA-D) activity from the brain, liver and kidney of adult mice (Swiss albine). In vitro experiments showed that the aluminum sulfate concentration needed to inhibit the enzyme activity was 1.0-5.0 mM (N = 3) in brain, 4.0-5.0 mM (N = 3) in liver and 0.0-5.0 mM (N = 3) in kidney. The in vivo experiments were performed on three groups for one month: 1) control animals (N = 8); 2) animals treated with 1 g per cent (34 mM) sodium citrate (N = 8) and 3) animals treated with 1 g per cent (34 mM) sodium citrate plus 3.3 g per cent (49.5 mM) aluminum sulfate (N = 8). Exposure to aluminum sulfate in drinking water inhibited ALA-D activity in kidney (23.3 + ou - 3.7 per cent, mean + ou - SEM, P<0.05 compared to control), but enhanced it in liver (31.2 + ou - 15.0 per cent, mean + ou - SEM, P<0.05). The concentrations of aluminum in the brain, liver and kidney of adult mice were determined by graphite furnace atomic absorption spectrometry. The aluminum concentrations increased significantly in the liver (527 + ou - 3.9 per cent, mean + ou - SEM, P<0.05) and kidney (283 + ou - 1.7 per cent, mean + ou - SEM, P<0.05) but did not change in the brain of aluminum-exposed mice. One of the most important and striking observations was the increase in hepatic aluminum concentration in the mice treated only with 1 g per cent sodium citrate (34 mM) (217 + ou - 1.5 per cent, mean + ou - SEM, P<0.05 compared to control). These results show that aluminum interferes with delta-aminolevulinate dehydratase activity in vitro and in vivo. The accumulation of this element was in the order: liver > kidney > brain. Furthermore, aluminum had only inhibitory properties in vitro, while in vivo it inhibited or stimulated the enzyme depending on the organ studied.


Subject(s)
Animals , Mice , Male , Female , Aluminum/pharmacology , Brain/enzymology , Kidney/enzymology , Liver/enzymology , Porphobilinogen Synthase/metabolism , Sulfates/pharmacology , Brain/drug effects , Citrates , Kidney/drug effects , Liver/drug effects , Porphobilinogen Synthase/antagonists & inhibitors
4.
Rev. argent. dermatol ; 70(4): 209-15, oct.-dic. 1989. ilus
Article in Spanish | LILACS | ID: lil-102158

ABSTRACT

Se ha investigado la acción de concentraciones variables de uroporfirina I, uroporfirinógeno I y mezclas de porfirina aisladas de plasma y orina de pacientes porfíricos sobre la actividad de la alfa-aminolevúlico dehidrasa (ALA-D) de sangre de individuos normales y pacientes con PCT, en diferentes condiciones de iluminación, a 37-C y luego de 2 horas de exposición a la porfirina. La Uro I y el Urogen I inactivan la enzima en la oscuridad, efecto dependiente de la concentración que llega al 30-60% a valore de 10 µM del tetrapirrol. El Urogen I es un inhibidor más efectivo que la Uro I. La presencia de cantidades variables de mezclas de porfirinas aisladas del plasma y orina de pacientes con PCT, en la enzima de sangre normal y porfírica, produce también una inactivación independiente y una dependiente de la luz que aumenta a concentraciones crecientes de la mezcla, a partir de un valor umbral del orden de 1 - 1,5 µM por debajo del cual, los pigmentos no ejercen ningún tipo de inhibición


Subject(s)
Humans , Porphobilinogen Synthase/blood , Porphyrias/enzymology , Porphyrins/pharmacology , Uroporphyrins/blood , Hydroxymethylbilane Synthase/antagonists & inhibitors , Porphobilinogen Synthase/antagonists & inhibitors , Structure-Activity Relationship , Ultraviolet Rays , Uroporphyrins/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL